Skip to content

TENAYA THERAPEUTICS, INC.

TNYA

CIK 0001858848

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$89.69M
+18.5% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.59
+55.0% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$102.88M
Q1 May 2026
Cash
$80.89M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
217M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings